[HTML][HTML] Impact of age and vaccination history on long-term serological responses after symptomatic B. pertussis infection, a high dimensional data analysis

I van Twillert, AA Bonačić Marinović, B Kuipers… - Scientific reports, 2017 - nature.com
I van Twillert, AA Bonačić Marinović, B Kuipers, JAM van Gaans-van den Brink…
Scientific reports, 2017nature.com
Capturing the complexity and waning patterns of co-occurring immunoglobulin (Ig)
responses after clinical B. pertussis infection may help understand how the human host
gradually loses protection against whooping cough. We applied bi-exponential modelling to
characterise and compare B. pertussis specific serological dynamics in a comprehensive
database of IgG, IgG subclass and IgA responses to Ptx, FHA, Prn, Fim2/3 and OMV
antigens of (ex-) symptomatic pertussis cases across all age groups. The decay model …
Abstract
Capturing the complexity and waning patterns of co-occurring immunoglobulin (Ig) responses after clinical B. pertussis infection may help understand how the human host gradually loses protection against whooping cough. We applied bi-exponential modelling to characterise and compare B. pertussis specific serological dynamics in a comprehensive database of IgG, IgG subclass and IgA responses to Ptx, FHA, Prn, Fim2/3 and OMV antigens of (ex-) symptomatic pertussis cases across all age groups. The decay model revealed that antigen type and age group were major factors determining differences in levels and kinetics of Ig (sub) classes. IgG-Ptx waned fastest in all age groups, while IgA to Ptx, FHA, Prn and Fim2/3 decreased fast in the younger but remained high in older (ex-) cases, indicating an age-effect. While IgG1 was the main IgG subclass in response to most antigens, IgG2 and IgG3 dominated the anti-OMV response. Moreover, vaccination history plays an important role in post-infection Ig responses, demonstrated by low responsiveness to Fim2/3 in unvaccinated elderly and by elevated IgG4 responses to multiple antigens only in children primed with acellular pertussis vaccine (aP). This work highlights the complexity of the immune response to this re-emerging pathogen and factors determining its Ig quantity and quality.
nature.com